Jyong Biotech Ltd. (MENS)

Jyong Biotech Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	0.1	1.74	2.27	0.55	5.16
Cash & Short-Term Investments	0.1	1.74	2.27	0.55	5.16
Cash Growth	-98.08%	-23.39%	312.70%	-89.32%	-
Other Current Assets	0.1	0.1	0.1	0.26	0.4
Total Current Assets	0.2	1.84	2.46	2.65	6.22
Net Property, Plant & Equipment	3.34	3.54	6	6.78	6.61
Other Long-Term Assets	2.9	2.87	0.28	0.01	0.01
Total Assets	6.44	8.25	8.75	9.43	12.84
Accounts Payable	0.01	0	0	0.05	0.03
Accrued Expenses	0.97	1.18	0.89	1.06	0.79
Short-Term Debt	7.1	7.9	7.17	4.76	4.66
Current Portion of Long-Term Debt	0.36	0.08	0.48	0.18	0.17
Current Portion of Leases	0.16	0.13	0.17	0.25	0.13
Other Current Liabilities	3.33	4.97	4.2	0	0
Total Current Liabilities	11.93	14.26	12.91	6.29	5.78
Long-Term Debt	9.67	8.52	6.32	6.26	7.62
Long-Term Leases	0.08	0.07	0.12	0.35	0.36
Other Long-Term Liabilities	19.69	19.47	19.04	19.86	18.29
Total Long-Term Liabilities	29.43	28.06	25.47	26.46	26.27
Total Liabilities	41.37	42.32	38.38	32.76	32.05
Common Stock	0	0	0	0	0
Treasury Stock	-16.37	-16.37	-16.37	-16.37	-16.37
Additional Paid-in Capital	11.81	11.81	11.81	11.81	11.81
Accumulated Other Comprehensive Income	1.02	0.55	0.59	0.27	0.19
Retained Earnings	-31.39	-30.06	-25.66	-19.03	-14.83
Shareholders' Equity	-34.93	-34.07	-29.63	-23.33	-19.2
Total Liabilities & Equity	6.44	8.25	8.75	9.43	12.84
Total Debt	17.37	16.69	14.25	11.79	12.94
Net Cash (Debt)	-17.27	-14.95	-11.98	-11.24	-7.78
Net Cash Per Share	-0.24	-0.21	-0.17	-0.16	-0.11
Book Value	-34.93	-34.07	-29.63	-23.33	-19.2
Book Value Per Share	-0.49	-0.48	-0.41	-0.33	-0.27
Tangible Book Value	-34.93	-34.07	-29.63	-23.33	-19.2
Tangible Book Value Per Share	-0.49	-0.48	-0.41	-0.33	-0.27

Updated Jun 30, 2024. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q